Article info
Correspondence
Further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy
- Correspondence to Dr Jay Ramchand, Department of Medicine, Department of Cardiology, University of Melbourne, Parkville VIC 3010, Australia; jay.ramchand{at}unimelb.edu.au
Citation
Further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy
Publication history
- First published November 14, 2018.
Online issue publication
January 18, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.